Latin America Cancer Biomarkers Market Size, Share, Growth, Trends, and Industry Analsis: By Disease, By Type, By Profiling Technology, By Application and Country Forecast 2020-2031

download arrow download arrow Download Sample
settings arrow settings arrow email us

Latin America Cancer Biomarkers Market Size, Share, Growth, Trends, and Industry Analsis: By Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, Other Diseases), By Type (Protein Biomarkers, Genetic Biomarkers, Other Types), By Profiling Technology (OMICS Technology, Imaging Technology, Immunoassays, Cytogenetics), By Application (Diagnostics, Drug Discovery and Development, Prognostics, Risk Assessment, Others) and Country Forecast 2020-2031

checked icon checked icon arrow_drop_down
checked icon Single User License $3100 $2480
checked icon Multiple User License $4600 $3680
checked icon Corporate User License $6900 $5520

Latin America Cancer Biomarkers Market size was valued at US$ x million in 2024 and is expected to reach US$ x million by 2031, growing at a significant CAGR of x% from 2025-2031. The market report provides a detailed overview of the market, which has been segmented by disease, type, filing technology, and application. By disease, the Latin American cancer biomarkers market has been segmented into In Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Other Diseases. The Breast Cancer segment is likely the largest and fastest-growing in terms of various disease types. The Latin American cancer biomarkers market has been segmented into Protein Biomarkers, Genetic Biomarkers, and Other Types. The Protein Biomarkers accounted for a significant revenue share in 2021. By profiling technology, the Latin American cancer biomarkers market has been segmented into OMICS Technology, Imaging Technology, Immunoassays, and Cytogenetics. OMICS Technology is expected to account for a significant revenue share from 2024 to 2030. Based on application, the Latin American cancer biomarkers are segmented into Diagnostics, Drug Discovery and Development, Prognostics, Risk Assessment, and Others. According to precision business insights, the Diagnostics segment is predicted to register the fastest growth rate during the forecast period.

Key Development:

  • In November 2020, Agilent Technologies Inc. launched the Biomarker Pathologist Training Program, a global initiative designed to help pathologists precisely score biomarkers.

Latin America Cancer Biomarkers Market Dynamics

The importance of biological and targeted medicinal therapies, as well as the accuracy, dependability, and technological developments of cancer biomarkers, are expected to drive the growth of the cancer biomarkers market.

Latin America Cancer Biomarkers Market Segmentation Analysis

Report Benchmarks

Details

By Disease

  • Prostate Cancer,
  • Breast Cancer,
  • Lung Cancer,
  • Colorectal Cancer,
  • Cervical Cancer,
  • Other Diseases

By Type

  • Protein Biomarkers,
  • Genetic Biomarkers,
  • Other Types

By Application

  • Diagnostics,
  • Drug Discovery and Development,
  • Prognostics,
  • Risk Assessment,
  • Others

Key Features of the Report

  • The Latin America cancer biomarkers market report provides granular level information about the market size, regional market share, historic market (2020-2024), and forecast (2025-2031)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The Latin America cancer biomarkers market size was valued at US$ x million in 2024 and is expected to reach US$ x million by 2031, growing at a significant CAGR of x% from 2025-2031

The market report data: (Latin America, Brazil, Mexico, Rest of LA)

The market key players are: Thermo Fisher Scientific Bio-Rad Laboratories Roche Diagnostics Qiagen N.V. Illumina GE Healthcare Agilent Technologies Biomrieux SA Merck & Co. Abbott Laboratories Becton, Dickinson and Company

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Latin America Cancer Biomarkers Market Introduction
2.1. Latin America Cancer Biomarkers Market Taxonomy
2.2. Latin America Cancer Biomarkers Market Definitions
2.2.1. Disease
2.2.2. Type
2.2.3. Profiling Technology
2.2.4. Application
3. Latin America Cancer Biomarkers Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Latin America Cancer Biomarkers Market Dynamic Factors - Impact Analysis
3.6. Latin America Cancer Biomarkers Market Competition Landscape
4. Latin America Cancer Biomarkers Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031
4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Latin America Cancer Biomarkers Market, By Disease, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
5.1. Prostate Cancer
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Breast Cancer
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Lung Cancer
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Colorectal Cancer
5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Cervical Cancer
5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Other Diseases
5.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
6. Latin America Cancer Biomarkers Market Forecast, By Type, 2019 - 2023 and Forecast, 2020 2026 (Revenue, USD Mn)
6.1. Protein Biomarkers
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Genetic Biomarkers
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Other Types
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Latin America Cancer Biomarkers Market Forecast, By Profiling Technology, 2019 - 2023 and Forecast, 2020 2026 (Revenue, USD Mn)
7.1. OMICS Technology
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Imaging Technology
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Immunoassays
7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Cytogenetics
7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Latin America Cancer Biomarkers Market Forecast, By Application, 2020 - 2024 and Forecast, 2025 - 2031
8.1. Diagnostics
8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Drug Discovery and Development
8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Prognostics
8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Risk Assessment
8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Others
8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
9. Latin America Cancer Biomarkers Market Forecast, By Country, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
9.1. Brazil
9.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Mexico
9.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Argentina
9.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Rest of Latin America
9.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Latin America Cancer Biomarkers Market - Opportunity Analysis Index, By Disease, Type, Profiling Technology, Application and Country, 2024 - 2030
10. Latin America Cancer Biomarkers Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
10.1. Disease Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Prostate Cancer
10.1.2. Breast Cancer
10.1.3. Lung Cancer
10.1.4. Colorectal Cancer
10.1.5. Cervical Cancer
10.1.6. Other Diseases
10.2. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Protein Biomarkers
10.2.2. Genetic Biomarkers
10.2.3. Other Types
10.3. Profiling Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. OMICS Technology
10.3.2. Imaging Technology
10.3.3. Immunoassays
10.3.4. Cytogenetics
10.4. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Diagnostics
10.4.2. Drug Discovery and Development
10.4.3. Prognostics
10.4.4. Risk Assessment
10.4.5. Others
10.5. Latin America Cancer Biomarkers Market - Opportunity Analysis Index, By Disease, Type, Profiling Technology, Application and Country, 2024 - 2030
10.6. Latin America Cancer Biomarkers Market Dynamics Trends
11. Latin America Cancer Biomarkers Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
11.1. Disease Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Prostate Cancer
11.1.2. Breast Cancer
11.1.3. Lung Cancer
11.1.4. Colorectal Cancer
11.1.5. Cervical Cancer
11.1.6. Other Diseases
11.2. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Protein Biomarkers
11.2.2. Genetic Biomarkers
11.2.3. Other Types
11.3. Profiling Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. OMICS Technology
11.3.2. Imaging Technology
11.3.3. Immunoassays
11.3.4. Cytogenetics
11.4. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Diagnostics
11.4.2. Drug Discovery and Development
11.4.3. Prognostics
11.4.4. Risk Assessment
11.4.5. Others
11.5. Latin America Cancer Biomarkers Market - Opportunity Analysis Index, By Disease, Type, Profiling Technology, Application and Country, 2024 - 2030
11.6. Latin America Cancer Biomarkers Market Dynamics Trends
12. Latin America Cancer Biomarkers Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
12.1. Disease Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Prostate Cancer
12.1.2. Breast Cancer
12.1.3. Lung Cancer
12.1.4. Colorectal Cancer
12.1.5. Cervical Cancer
12.1.6. Other Diseases
12.2. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Protein Biomarkers
12.2.2. Genetic Biomarkers
12.2.3. Other Types
12.3. Profiling Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. OMICS Technology
12.3.2. Imaging Technology
12.3.3. Immunoassays
12.3.4. Cytogenetics
12.4. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Diagnostics
12.4.2. Drug Discovery and Development
12.4.3. Prognostics
12.4.4. Risk Assessment
12.4.5. Others
12.5. Latin America Cancer Biomarkers Market - Opportunity Analysis Index, By Disease, Type, Profiling Technology, Application and Country, 2024 - 2030
12.6. Latin America Cancer Biomarkers Market Dynamics Trends
13. Latin America Cancer Biomarkers Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn)
13.1. Disease Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Prostate Cancer
13.1.2. Breast Cancer
13.1.3. Lung Cancer
13.1.4. Colorectal Cancer
13.1.5. Cervical Cancer
13.1.6. Other Diseases
13.2. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Protein Biomarkers
13.2.2. Genetic Biomarkers
13.2.3. Other Types
13.3. Profiling Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. OMICS Technology
13.3.2. Imaging Technology
13.3.3. Immunoassays
13.3.4. Cytogenetics
13.4. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Diagnostics
13.4.2. Drug Discovery and Development
13.4.3. Prognostics
13.4.4. Risk Assessment
13.4.5. Others
13.5. Latin America Cancer Biomarkers Market - Opportunity Analysis Index, By Disease, Type, Profiling Technology, Application and Country, 2024 - 2030
13.6. Latin America Cancer Biomarkers Market Dynamics Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Disease & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Thermo Fisher Scientific
14.2.2. Bio-Rad Laboratories
14.2.3. Roche Diagnostics
14.2.4. Qiagen N.V.
14.2.5. Illumina
14.2.6. GE Healthcare
14.2.7. Agilent Technologies
14.2.8. Biomérieux SA
14.2.9. Merck & Co.
14.2.10. Abbott Laboratories
14.2.11. Becton, Dickinson and Company
14.2.12. Quest Diagnostics
15. Research Methodology
16. Key Assumptions and Acronyms

Key Market Players

  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Roche Diagnostics
  • Qiagen N.V.
  • Illumina
  • GE Healthcare
  • Agilent Technologies
  • Biomrieux SA
  • Merck & Co.
  • Abbott Laboratories
  • Becton, Dickinson and Company

Related Industry Reports

Healthcare Diagnostics Market

Dental Market

Antibody Productions Market

Malignant Mesotheliomas Market